225 related articles for article (PubMed ID: 21381334)
1. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
[TBL] [Abstract][Full Text] [Related]
2. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
3. [Specific humoral immunity after single immunization with mumps vaccine: data of a 3-year follow-up].
Otrashevskaia AV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2011; 56(3):45-8. PubMed ID: 21786628
[TBL] [Abstract][Full Text] [Related]
4. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
5. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
6. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
7. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
Rasheed MAU; Hickman CJ; McGrew M; Sowers SB; Mercader S; Hopkins A; Grimes V; Yu T; Wrammert J; Mulligan MJ; Bellini WJ; Rota PA; Orenstein WA; Ahmed R; Edupuganti S
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19071-19076. PubMed ID: 31481612
[TBL] [Abstract][Full Text] [Related]
8. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
[TBL] [Abstract][Full Text] [Related]
9. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
[TBL] [Abstract][Full Text] [Related]
10. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
[TBL] [Abstract][Full Text] [Related]
11. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.
Narita M; Matsuzono Y; Takekoshi Y; Yamada S; Itakura O; Kubota M; Kikuta H; Togashi T
Clin Diagn Lab Immunol; 1998 Nov; 5(6):799-803. PubMed ID: 9801337
[TBL] [Abstract][Full Text] [Related]
13. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
14. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
[TBL] [Abstract][Full Text] [Related]
15. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
Vaidya SR; Dvivedi GM; Jadhav SM
Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
[TBL] [Abstract][Full Text] [Related]
16. [Mumps vaccine virus transmission].
Otrashevskaia EV; Kulak MV; Otrashevskaia AV; Karpov IA; Fisenko EG; Ignat'ev GM
Vopr Virusol; 2013; 58(6):42-5. PubMed ID: 24772647
[TBL] [Abstract][Full Text] [Related]
17. Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.
Vermeire T; Barbezange C; Francart A; Hamouda A; Litzroth A; Hutse V; Martens L; Vandermarliere E; Van Gucht S
Clin Microbiol Infect; 2019 Jul; 25(7):907.e1-907.e6. PubMed ID: 30502489
[TBL] [Abstract][Full Text] [Related]
18. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements.
Park DW; Nam MH; Kim JY; Kim HJ; Sohn JW; Cho Y; Song KJ; Kim MJ
Vaccine; 2007 Jun; 25(24):4665-70. PubMed ID: 17498856
[TBL] [Abstract][Full Text] [Related]
19. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
[TBL] [Abstract][Full Text] [Related]
20. [Testing for the safety, reactogenicity and antigenic properties of a live thermostable mumps vaccine made from the Leningrad-3 strain].
Iuminova HV; Liashenko VA; Krasnova VP; Krivenkova VN; Goliazhenkova MIu; Unanov SS
Vopr Virusol; 1991; 36(4):310-2. PubMed ID: 1796587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
